Demand for COVID-19 vaccines in Ghana

COVID-19 vaccine hesitancy is higher among the urban poor than the general population in Ghana. A University of Ghana and ETH-NADEL policy brief analyses the demand for the vaccine in poor settlements in Accra and sheds light on the drivers of and barriers to demand.

COVAX rollout: COVID-19 vaccinations begin in Ghana – nurse prepares vaccine on March 2, 2021. Photo: WHO / Blink Media - Nana Kofi Acquah, CC BY-SA 3.0 IGO
COVAX rollout: COVID-19 vaccinations begin in Ghana – nurse prepares vaccine on March 2, 2021. Photo: WHO / Blink Media - Nana Kofi Acquah, CC BY-SA 3.0 IGO

Vaccine availability is not the only challenge standing in the way of national and global herd immunity, which requires over 85% of the population to be vaccinated. Vaccine hesitancy is another global concern. In our study, we find that in Ghana only 70% of the urban poor are willing to receive a vaccine.

Concerns about side effects and effectiveness are major barriers, while general vaccine hesitancy does not seem to be an issue – different to many other countries. Knowledge about COVID-19 and trust in the government are essential for creating a positive attitude towards vaccines.

Based on the results of this survey, the authors of the policy brief, Koku Awoonor-Williams, Edward Asiedu, Kathrin Durizzo, Isabel Günther, and Dawit Sebhatu emphasize that increasing the population's knowledge about the pandemic and trust in the government is crucial for a successful vaccination campaign. Furthermore, authorities are strongly encouraged to maintain the policy of voluntary and free COVID-19 vaccination.

DownloadHere you can find the policy brief (PDF, 229 KB)
 

JavaScript has been disabled in your browser